Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Slideshow
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
Trelegy Ellipta is now approved for the maintenance treatment of asthma in patients aged 18 years and older.
Learn more about this new indication with our slideshow, complete drug monograph, and downloadable PDF.
This article originally appeared on MPR
